Alnylam Pharmaceuticals, Inc. (ALNY)
Select a metric from the list below to chart it
Dec '02
Dec '06
Dec '10
Dec '14
Dec '18
Dec '22
| Income Statement | Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 47.2 | 50.6 | 41.1 | 47.2 | 89.9 | 74.9 | 219.8 | 492.9 | 844.3 | 1,037.4 | |
| Revenue % Chg. | -29.3% | 7.2% | -18.7% | 14.8% | 90.7% | -16.7% | 193.4% | 124.3% | 71.3% | 22.9% | |
| Cost of Revenue | — | — | — | — | — | 1.8 | 25.1 | 78.1 | 140.1 | 168.8 | |
| Cost of Revenue % Chg. | — | — | — | — | — | — | 1290.8% | 211.4% | 79.6% | 20.5% | |
| Gross Profit | — | — | — | — | — | 73.1 | 194.7 | 414.8 | 704.1 | 868.6 | |
| Gross Profit % Chg. | — | — | — | — | — | — | 166.3% | 113.1% | 69.8% | 23.4% | |
| Gross Profit Margin | — | — | — | — | — | 97.6% | 88.6% | 84.2% | 83.4% | 83.7% | |
| Gross Profit Margin % Chg. | — | — | — | — | — | — | -9.2% | -5.0% | -0.9% | 0.4% | |
| R&D Expenses | 113.0 | 190.2 | 276.5 | 382.4 | 390.6 | 505.4 | 655.1 | 654.8 | 792.2 | 883.0 | |
| R&D Expenses % Chg. | 30.5% | 68.4% | 45.3% | 38.3% | 2.2% | 29.4% | 29.6% | -0.0% | 21.0% | 11.5% | |
| Selling, General, & Admin Expenses | 27.2 | 44.5 | 60.6 | 89.4 | 199.4 | 382.4 | 479.0 | 588.4 | 620.6 | 770.7 | |
| Selling, General, & Admin Expenses % Chg. | -37.9% | 64.0% | 36.1% | 47.4% | 123.1% | 91.8% | 25.3% | 22.8% | 5.5% | 24.2% | |
| Operating Income | -92.9 | -405.0 | -296.0 | -424.6 | -500.1 | -814.7 | -939.4 | -828.4 | -708.7 | -785.1 | |
| Operating Income % Chg. | 28.2% | 335.7% | 26.9% | 43.4% | 17.8% | 62.9% | 15.3% | 11.8% | 14.5% | 10.8% | |
| Operating Income Margin | -197.0% | -801.0% | -720.3% | -900.3% | -556.2% | -1087.6% | -427.5% | -168.1% | -83.9% | -75.7% | |
| Operating Income Margin % Chg. | 1.6% | 306.5% | 10.1% | 25.0% | 38.2% | 95.5% | 60.7% | 60.7% | 50.1% | 9.8% | |
| Total Other Income/Expenses Net | 1.0 | 4.4 | 5.9 | 14.5 | 9.2 | 54.0 | 54.2 | -27.2 | -143.5 | -341.9 | |
| Total Other Income/Expenses Net % Chg. | -92.1% | 328.2% | 35.6% | 144.0% | -36.4% | 486.1% | 0.3% | — | 428.3% | 138.3% | |
| Income Before Tax | -91.9 | -400.6 | -290.1 | -410.1 | -490.9 | -760.7 | -885.3 | -855.6 | -852.1 | -1,127.0 | |
| Income Before Tax % Chg. | 21.2% | 335.8% | 27.6% | 41.4% | 19.7% | 55.0% | 16.4% | 3.3% | 0.4% | 32.3% | |
| Income Before Tax Margin | -194.9% | -792.3% | -705.8% | -869.6% | -545.9% | -1015.5% | -402.8% | -173.6% | -100.9% | -108.6% | |
| Income Before Tax Margin % Chg. | 11.5% | 306.6% | 10.9% | 23.2% | 37.2% | 86.0% | 60.3% | 56.9% | 41.9% | 7.6% | |
| Income Tax Expense | -2.7 | -40.2 | — | — | — | 0.8 | 0.9 | 2.7 | 0.7 | 4.2 | |
| Income Tax Expense % Chg. | 74.5% | 1392.0% | — | — | — | — | 4.9% | 210.7% | -74.6% | 512.2% | |
| Net Income | -89.2 | -360.4 | -290.1 | -410.1 | -490.9 | -761.5 | -886.1 | -858.3 | -852.8 | -1,131.2 | |
| Net Income % Chg. | 15.8% | 303.9% | 19.5% | 41.4% | 19.7% | 55.1% | 16.4% | 3.1% | 0.6% | 32.6% | |
| Net Income Margin | -189.2% | -712.8% | -705.8% | -869.6% | -545.9% | -1016.6% | -403.2% | -174.1% | -101.0% | -109.0% | |
| Net Income Margin % Chg. | 19.1% | 276.8% | 1.0% | 23.2% | 37.2% | 86.2% | 60.3% | 56.8% | 42.0% | 7.9% | |
| Weighted Avg. Shares Out | 61.6 | 74.3 | 84.0 | 85.6 | 90.6 | 100.6 | 109.3 | 115.0 | 118.5 | 121.7 | |
| Weighted Avg. Shares Out % Chg. | 22.4% | 20.7% | 13.1% | 1.9% | 5.8% | 11.1% | 8.6% | 5.2% | 3.0% | 2.7% | |
| EPS | -1.5 | -4.9 | -3.5 | -4.8 | -5.4 | -7.6 | -8.1 | -7.5 | -7.2 | -9.3 | |
| EPS % Chg. | 31.3% | 234.5% | 28.9% | 38.8% | 13.2% | 39.7% | 7.1% | 8.0% | 3.5% | 29.2% | |
| Weighted Avg. Shares Out Dil | 61.6 | 74.3 | 84.0 | 85.6 | 90.6 | 100.6 | 109.3 | 115.0 | 118.5 | 121.7 | |
| Weighted Avg. Shares Out Dil % Chg. | 22.4% | 20.7% | 13.1% | 1.9% | 5.8% | 11.1% | 8.6% | 5.2% | 3.0% | 2.7% | |
| EPS Diluted | -1.5 | -4.9 | -3.5 | -4.8 | -5.4 | -7.6 | -8.1 | -7.5 | -7.2 | -9.3 | |
| EPS Diluted % Chg. | 31.3% | 234.5% | 28.9% | 38.8% | 13.2% | 39.7% | 7.1% | 8.0% | 3.5% | 29.2% | |
| Interest Income | 1.1 | 2.6 | 5.9 | 8.3 | 12.2 | 29.3 | 33.4 | 11.8 | 1.6 | 24.8 | |
| Interest Income % Chg. | 9.4% | 139.4% | 129.0% | 41.8% | 47.3% | 139.1% | 14.3% | -64.7% | -86.6% | 1471.1% | |
| Interest Expense | 1.1 | 2.6 | 5.9 | 8.3 | 12.2 | 29.3 | 33.4 | 84.5 | 143.0 | 156.0 | |
| Interest Expense % Chg. | 9.4% | 139.4% | 129.0% | 41.8% | 47.3% | 139.1% | 14.3% | 152.6% | 69.3% | 9.1% | |
| EBIT | -91.9 | -400.6 | -290.1 | -410.1 | -490.9 | -760.7 | -885.3 | -928.3 | -993.6 | -1,258.2 | |
| EBIT % Chg. | 21.2% | 335.8% | 27.6% | 41.4% | 19.7% | 55.0% | 16.4% | 4.9% | 7.0% | 26.6% | |
| EBIT Margin | -194.9% | -792.3% | -705.8% | -869.6% | -545.9% | -1015.5% | -402.8% | -188.3% | -117.7% | -121.3% | |
| EBIT Margin % Chg. | 11.5% | 306.6% | 10.9% | 23.2% | 37.2% | 86.0% | 60.3% | 53.2% | 37.5% | 3.1% | |
| Depreciation & Amortization | 10.2 | 11.9 | 19.1 | 15.1 | 13.4 | 6.4 | 54.4 | 74.4 | 89.7 | 85.6 | |
| Depreciation & Amortization % Chg. | 13.2% | 16.6% | 59.7% | -20.6% | -11.7% | -51.9% | 744.9% | 36.9% | 20.5% | -4.6% | |
| EBITDA | -81.7 | -388.7 | -271.0 | -395.0 | -477.5 | -754.2 | -830.9 | -853.9 | -903.9 | -1,172.6 | |
| EBITDA % Chg. | 24.0% | 375.8% | 30.3% | 45.7% | 20.9% | 58.0% | 10.2% | 2.8% | 5.9% | 29.7% | |
| EBITDA Margin | -173.2% | -768.7% | -659.5% | -837.5% | -531.1% | -1006.9% | -378.1% | -173.2% | -107.1% | -113.0% | |
| EBITDA Margin % Chg. | 7.5% | 343.9% | 14.2% | 27.0% | 36.6% | 89.6% | 62.4% | 54.2% | 38.2% | 5.6% |